Is BioXcel Therapeutics, Inc. (BTAI) a Buy, Sell, or Hold?
NASDAQ : BTAI
BioXcel Therapeutics, Inc. — Analyst Ratings
$0.9495 USD
$0.05 (5.3%)
- Volume
- 303.96K
- Average Volume
- 923.25K
- Market Capitalization
- $29.32M
- P/E Ratio
- -0.14
- Dividend Yield
- 0.00%
- Price Target
- $10.00
- Year High
- $8.08
- Year Low
- $0.74
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.62
Analyst Consensus Summary
Consensus Rating
Sell
15 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-90.5%
vs Current Price
Price Target
$10.00
Average TargetPrice Target Range
Lowest Target
$1.00
-5.0% DOWNSIDE
Average Target
$10.00
Median Estimate
Highest Target
$25.00
-96.2% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 15
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 8 | 6 | 1 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Mizuho Securities | Graig Suvannavejh | $1 | $0.5889 | 2024-09-23 03:04 AM | 69.8% |
| H.C. Wainwright | Raghuram Selvaraju | $10 | $2.9 | 2024-04-15 02:44 AM | 244.8% |
| Mizuho Securities | Graig Suvannavejh | $4 | $3.975 | 2023-08-15 10:02 AM | 0.6% |